News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
New Enterprise Associates 16, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2022 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 7.3% stake in Allakos Inc. |
| 09/28/2020 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 11.8% stake in Metacrine, Inc. |
| 07/07/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/13/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/30/2019 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 18.2% stake in Mirum Pharmaceuticals, Inc. |
| 05/20/2019 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 25% stake in Trevi Therapeutics, Inc. |
| 10/25/2018 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 17.8% stake in Marker Therapeutics, Inc. |
| 07/27/2018 |
SC 13D
| New Enterprise Associates 16, L.P. reports a 5.6% stake in Allakos Inc. |
| 01/26/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/29/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|